These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

873 related items for PubMed ID: 10944779

  • 1. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
    Fathy M, Sheha M.
    Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
    [Abstract] [Full Text] [Related]

  • 2. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 3. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 4. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO, Omoruyi SI, Oladimeji FA.
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [Abstract] [Full Text] [Related]

  • 5. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J, Qiu L, Gao J, Jin Y.
    Int J Pharm; 2006 Apr 07; 312(1-2):137-43. PubMed ID: 16459034
    [Abstract] [Full Text] [Related]

  • 6. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N, Ordu S.
    Drug Dev Ind Pharm; 1998 Jan 07; 24(1):19-25. PubMed ID: 15605593
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
    Sridevi S, Chauhan AS, Chalasani KB, Jain AK, Diwan PV.
    Pharmazie; 2003 Nov 07; 58(11):807-10. PubMed ID: 14664337
    [Abstract] [Full Text] [Related]

  • 8. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
    Zingone G, Rubessa F.
    Int J Pharm; 2005 Mar 03; 291(1-2):3-10. PubMed ID: 15707726
    [Abstract] [Full Text] [Related]

  • 9. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
    Pralhad T, Rajendrakumar K.
    J Pharm Biomed Anal; 2004 Feb 04; 34(2):333-9. PubMed ID: 15013147
    [Abstract] [Full Text] [Related]

  • 10. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
    Villaverde J, Morillo E, Pérez-Martínez JI, Ginés JM, Maqueda C.
    J Agric Food Chem; 2004 Feb 25; 52(4):864-9. PubMed ID: 14969543
    [Abstract] [Full Text] [Related]

  • 11. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M, Bećirević-Laćan M, Kwokal A, Cetina-Cizmek B.
    Acta Pharm; 2005 Sep 25; 55(3):223-36. PubMed ID: 16375834
    [Abstract] [Full Text] [Related]

  • 12. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL, Pore YV, Kuchekar BS, Late SG.
    Pharmazie; 2008 Apr 25; 63(4):282-5. PubMed ID: 18468387
    [Abstract] [Full Text] [Related]

  • 13. Interactions between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin.
    Palmieri GF, Wehrlé P, Martelli S.
    Drug Dev Ind Pharm; 1998 Jul 25; 24(7):653-60. PubMed ID: 9876510
    [Abstract] [Full Text] [Related]

  • 14. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
    Garnero C, Longhi M.
    J Pharm Biomed Anal; 2007 Nov 30; 45(4):536-45. PubMed ID: 17851014
    [Abstract] [Full Text] [Related]

  • 15. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J, Dhiman N, Parmar VK, Sardana S, Bharatam PV, Aneja R, Chandra R, Katyal A.
    Cancer Chemother Pharmacol; 2010 Feb 30; 65(3):537-48. PubMed ID: 19597818
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
    Yap KL, Liu X, Thenmozhiyal JC, Ho PC.
    Eur J Pharm Sci; 2005 May 30; 25(1):49-56. PubMed ID: 15854800
    [Abstract] [Full Text] [Related]

  • 17. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJ.
    Eur J Pharm Biopharm; 2007 Sep 30; 67(2):531-9. PubMed ID: 17451924
    [Abstract] [Full Text] [Related]

  • 18. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
    Rawat S, Jain SK.
    Eur J Pharm Biopharm; 2004 Mar 30; 57(2):263-7. PubMed ID: 15018983
    [Abstract] [Full Text] [Related]

  • 19. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
    Lin SY, Hsu CH, Sheu MT.
    J Pharm Biomed Anal; 2010 Nov 02; 53(3):799-803. PubMed ID: 20619996
    [Abstract] [Full Text] [Related]

  • 20. Availability of phenindione-beta-cyclodextrin inclusion complex.
    Tous SS, el-Sayed AM, el-Harras SA, Jun HW.
    Pharmazie; 1992 May 02; 47(5):365-8. PubMed ID: 1409827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.